Possible Legislation Regarding ESA Administration On The Horizon

A recent report from the HHS Office of Inspector General regarding erythropoiesis-stimulating agent administration to patients with chronic kidney failure could be laying the foundation for legislative action in the coming year, a staffer for House Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., said